학술논문
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study
Document Type
Article
Author
Source
In: Cardiovascular Drugs and Therapy . (Cardiovascular Drugs and Therapy, February 2024, 38(1):119-129)
Subject
Language
English
ISSN
15737241
09203206
09203206